BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/23/2016 6:33:00 PM | Browse: 1522 | Download: 2412
Publication Name World Journal of Gastroenterology
Manuscript ID 26747
Country Croatia
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?
Manuscript Source Invited Manuscript
All Author List Ivana Mikolasevic, Lidija Orlic, Neven Franjic, Goran Hauser, Davor Stimac and Sandra Milic
Funding Agency and Grant Number
Corresponding Author Ivana Mikolasevic, MD, PhD, Department of Gastroenterology, UHC Rijeka, 51000 Rijeka, Croatia. ivana.mikolasevic@gmail.com
Key Words Non-alcoholic fatty liver disease; Transient elastography; Controlled attenuation parameter
Core Tip Non-alcoholic fatty liver disease (NAFLD) patients are at risk of NAFLD-related cirrhosis and hepatocellular carcinoma, particularly in the setting of liver fibrosis with concurrent metabolic syndrome. Transient elastography (TE) with controlled attenuation parameter (CAP) is a fast, reliable, repeatable non-invasive method for the assessment of liver steatosis and fibrosis. TE with CAP may be used to diagnose and monitor patients with NAFLD. TE with CAP is a favorable means of excluding advanced fibrosis.
Publish Date 2016-08-24 10:09
Citation Mikolasevic I, Orlic L, Franjic N, Hauser G, Stimac D, Milic S. Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? World J Gastroenterol 2016; 22(32): 7236-7251
URL http://www.wjgnet.com/1007-9327/full/v22/i32/7236.htm
DOI http://dx.doi.org/10.3748/wjg.v22.i32.7236
Full Article (PDF) WJG-22-7236.pdf
Full Article (Word) WJG-22-7236.doc